期刊
CURRENT CANCER DRUG TARGETS
卷 12, 期 1, 页码 23-43出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156800912798888956
关键词
Angiogenesis; bevacizumab; hypoxia-inducible factor; pazopanib; ranibizumab; sorafenib; tumor angiogenesis; vascular endothelial growth factor
类别
Angiogenesis is the formation of new blood vessels from the pre-existing vasculature. Besides its role in normal physiology, angiogenesis is significantly involved in many pathological conditions, including inflammation, cardiovascular diseases and cancer. Numerous studies have been undertaken in the area of tumor angiogenesis. It is known that pathological angiogenesis is necessary for tumors to proceed from avascular, dormant stage to vascular, sprouting stage and also contributes to their later invasion and metastasis. Playing a central role in tumor angiogenesis, vascular endothelial growth factor is considered as a key target in therapeutic approaches. This article aims to review the critical role of VEGF in tumor angiogenesis and the importance of VEGF-targeted strategies in cancer treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据